Current Studies
Clinical trials advance medical treatment and therapy to increase survival and quality of life.
Research improves the standard of care as we develop protocols to improve the prevention, diagnosis, treatment and rehabilitation of health conditions throughout the body.
Successful treatments we know today are the result of past clinical trials.
- Cardiology (1)
- COVID-19 (1)
- Gastroenterology (1)
- Genetics (1)
- Hematology (1)
- Neurovascular (1)
- Oncology/Cancer (20)
- Orthopedics (1)
- Pain Management (2)
- Pediatric Gastroenterology (1)
- Pulmonary (4)
- Radiation Therapy (10)
- Rheumatology (1)
- Urology (5)
- Bladder Cancer (1)
- Breast Cancer (1)
- Cancer (10)
- Cancer Screening (2)
- Chronic Pain (2)
- COVID-19 (1)
- Erectile Dysfunction (1)
- Erosive Esophagitis (1)
- Hepatocellular Carcinoma (2)
- Ischemic Stroke (1)
- Leukemia (1)
- Lupus (SLE) (1)
- Male Overactive Bladder (1)
- Metastatic Colorectal Cancer (2)
- Multiple Myeloma (1)
- Non-Small Cell Lung Cancer (1)
- Oropharyngeal Cancer (2)
- Osteoarthritis (1)
- Prostate Cancer (4)
- Prostatectomy (1)
- Radiation Therapy (3)
- Ulcerative Colitis (1)
- Urinary Urge Incontinence (UUI) (2)
Purpose
The purpose of this open-label, multicenter, phase IIIb, single-arm study is to characterize the efficacy and safety of the combination of ribociclib and standard adjuvant endocrine therapy (ET) on invasive breast cancer–free survival, in a close-to-clinical practice patient population with HR-positive (HR+), HER2-negative (HER2−), Anatomic Stage Group III, IIB, and a subset of Stage IIA Early Breast Cancer (EBC).
For more information please visit https://clinicaltrials.gov/study/NCT05827081?term=CLEE011O12001
Interested in Volunteering for the Study?
If you would like more information about this study, please call us at 318-212-8671 .
Share
